Quarterly report pursuant to Section 13 or 15(d)

Capitalization (Details)

v3.24.3
Capitalization (Details) - USD ($)
 9 Months Ended
May 24, 2024
Mar. 22, 2024
Jan. 10, 2024
Dec. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Subsidiary, Sale of Stock            
Proceeds from liability-classified warrants and private placement offering, net of offering costs paid         $ 40,547,000 $ 87,244,000
Maximum amount of shares allowed to be owned by related party (as a percent) 49.99%          
Ownership Interest Contigency, Trigger Percentage 40.00%          
Securities Purchase Agreement            
Subsidiary, Sale of Stock            
Shares issued (in shares) 67,400,000          
Sales of stock (in dollars per share) $ 0.6270          
Class A Common Stock            
Subsidiary, Sale of Stock            
Common stock, shares authorized (in shares)       800,000,000 800,000,000  
Common stock, par value (in dollars per share)       $ 0.0001 $ 0.0001  
Class A Common Stock | Securities Purchase Agreement            
Subsidiary, Sale of Stock            
Shares issued (in shares) 41,600,000          
Shares issued per transaction (in shares) 1          
Number of shares issuable per warrant (warrants) 1          
Exercise price (in dollars per share) $ 0.5020          
Class A Common Stock | Securities Purchase Agreement | Common Warrants            
Subsidiary, Sale of Stock            
Warrant issued for securities (in shares) 67,400,000          
Class A Common Stock | Securities Purchase Agreement | Pre-funded warrants            
Subsidiary, Sale of Stock            
Warrant issued for securities (in shares) 25,800,000          
Class A Common Stock | Private Placement | Pre-funded warrants            
Subsidiary, Sale of Stock            
Sale of Stock, Consideration Received on Transaction $ 39,800,000          
Offering cost 2,400,000          
Class A Common Stock | Private Placement | Pre-funded warrants | Warrants Classified As Liability            
Subsidiary, Sale of Stock            
Sale of Stock, Consideration Received on Transaction 33,200,000          
Class A Common Stock | Private Placement | Pre-funded warrants | Warrants Classified as Equity            
Subsidiary, Sale of Stock            
Sale of Stock, Consideration Received on Transaction $ 6,600,000          
Class V Common Stock            
Subsidiary, Sale of Stock            
Common stock, shares authorized (in shares)       205,000,000 205,000,000  
Common stock, par value (in dollars per share)       $ 0.0001 $ 0.0001  
Chief Executive Officer | Withholding Taxes Paid            
Subsidiary, Sale of Stock            
Transaction amount     $ 700,000      
Chief Executive Officer | Restricted stock units            
Equity-Based Compensation            
Vested (in shares)       1,500,000    
Line of Credit | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Funding provided   $ 25,000,000        
Percentage of upfront-fee   1.50%        
Line of Credit | Period Two | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Debt Instrument, Back End Fee   4.50%        
Line of Credit | Period Four | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Debt Instrument, Back End Fee   9.00%        
Line of Credit | Period Three | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Debt Instrument, Back End Fee   6.75%        
Line of Credit | Option One | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Interest rate   17.50%        
Paid in cash interest, percentage   8.00%        
Paid in kind interest, percentage   9.50%        
Line of Credit | Option Two | VGS 2 Promissory Note            
Subsidiary, Sale of Stock            
Paid in kind interest, percentage   17.50%